ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Astaxanthin Is a Longevity Promoter

Meta-analysis links vitamin D deficiency with increased risk of mortality during 10.5 year median pe...

Prevent Or Reverse Diabetes: An Amazing Herbal Intervention

Exercise and Vitamin D Better Together for Heart Health

VIDEO: Essential Oils for Weight Loss

Can Valerian Root Help You Sleep Better?

Eight servings of veggies a day is clearly best for the heart

The Many Wonders of Calming Sandalwood Oil

Fighting Statin-Induced Diabetes with CoQ10

Can Ginkgo Give Your Brain a Boost?

 
Print Page
Email Article

Fluoxetine Effective In Women With Fibromyalgia

  [ 160 votes ]   [ Discuss This Article ]
www.ProHealth.com • June 26, 2002


A DGReview of:"A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia"

Source: American Journal of Medicine
By Robert Short

The SSRI fluoxetine is effective and generally well tolerated in women with fibromyalgia.

A randomized, placebo-controlled, double-blind flexible-dose study of fluoxetine in 60 women with fibromyalgia was carried out by Dr Lesley Arnold and colleagues. Dr Arnold is based at the Women's Health Research program, Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio, United States.

The intent-to-treat analysis in women who had received fluoxetine showed significant improvement in the Fibromyalgia Impact Questionnaire (FIQ) total score, compared with women who received placebo (difference of -12). The FIQ pain score was also 2.2 points lower in fluoxetine-treated women compared with the control group. Similarly, the FIQ fatigue and depression scores were lower in the treated group compared with women who received placebo. Fluoxetine-treated women also showed significant improvement in the McGill Pain Questionnaire, relative to the placebo group of women.

The effects of fluoxetine on tender points and myalgic scores were not so clear-cut. Said Dr Arnold, "Although counts for the number of tender points and total myalgic scores improved more in the fluoxetine group than in the placebo group, these differences were not statistically significant."

Dr Arnold concluded, "Fluoxetine was found to be effective on most outcome measures and generally well tolerated in women with fibromyalgia."

The American Journal of Medicine 2002;112(3):191-197 "A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia"

The Study Abstract:  A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia
Lesley M. Arnold MD, Evelyn V. Hess MD, James I. Hudson MD, SM, Jeffrey A. Welge PhD, Sarah E. Berno BPh, and Paul E. Keck Jr MD.  Received: 3/19/2001. Revised: 9/19/2001. Accepted: 10/29/2001.

Purpose: To assess the efficacy of fluoxetine in the treatment of patients with fibromyalgia.

Subjects and methods: Sixty outpatients (all women, aged 21–71 years) with fibromyalgia were randomly assigned to receive fluoxetine (10–80 mg/d) or placebo for 12 weeks in a double-blind, parallel-group, flexible-dose study. The primary outcome measures were the Fibromyalgia Impact Questionnaire total score (score range, 0 [no impact] to 80) and pain score (score range, 0–10). Secondary measures included the McGill Pain Questionnaire, change in the number of tender points, and total myalgic score.

Results: In the intent-to-treat analysis, women who received fluoxetine (mean [± SD] dose, 45 ± 25 mg/d) had significant (P = 0.005) improvement in the Fibromyalgia Impact Questionnaire total score compared with those who received placebo, with a difference of –12 (95% confidence interval [CI]: –19 to –4). They also had significant (P = 0.002) improvement in the Fibromyalgia Impact Questionnaire pain score (difference, –2.2 [95% CI: –3.6 to –0.9]), as well as in the Fibromyalgia Impact Questionnaire fatigue (P = 0.05) and depression (P = 0.01) scores and the McGill Pain Questionnaire (P = 0.01), when compared with subjects who received placebo. Although counts for the number of tender points and total myalgic scores improved more in the fluoxetine group than in the placebo group, these differences were not statistically significant.

Conclusion: In a 12-week, flexible-dose, placebo-controlled trial, fluoxetine was found to be effective on most outcome measures and generally well tolerated in women with fibromyalgia.

Supported by an investigator-initiated grant from Eli Lilly and Company, Indianapolis, Indiana.Affiliations:
a Women's Health Research Program (LMA, SEB), Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio, USA. b Department of Internal Medicine (EVH), Division of Immunology, University of Cincinnati Medical Center, Cincinnati, Ohio, USA. c Biological Psychiatry Laboratory (JIH), McLean Hospital, Belmont, Massachusetts, USA. d Department of Psychiatry (JIH), Harvard Medical School, Boston, Massachusetts, USA. e Department of Biostatistics and Epidemiology (JIH), Harvard School of Public Health, Boston, Massachusetts, USA. f Biological Psychiatry Program (JAW, PEK), Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.

Copyright © 2002 Excerpta Medica Inc. All rights reserved.



Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Optimized Curcumin Longvida® FibroSleep™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Green Coffee Extract: Unique Obesity Intervention Green Coffee Extract: Unique Obesity Intervention
Natural Support for Mood, Sleep and Mental Focus? L-theanine Natural Support for Mood, Sleep and Mental Focus? L-theanine
Undenatured Type II Collagen - Chicken Soup for Your Joints Undenatured Type II Collagen - Chicken Soup for Your Joints
Astaxanthin - A Little-Known but Power-Packed Nutrient Astaxanthin - A Little-Known but Power-Packed Nutrient
Vital Molecule Increases Cellular Energy and Improves Cognitive Function Vital Molecule Increases Cellular Energy and Improves Cognitive Function

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map